3 ms·
The manufacturer doesn't know anything about this that isn't public information. Yes, two doses are almost certainly better than one. But those are not the cho
by BurningFrog 6y ago
The manufacturer doesn't know anything about this that isn't public information.
Yes, two doses are almost certainly better than one. But those are not the choices.
When there are far fewer doses than the number of people to vaccinate, the question is if it's better to give N people 2 shots, or 2N people 1 shot.
The test data looks like 1 dose gives ~80% protection vs ~95% for 2 doses. The 2x80% scenario is clearly better than 1x95%.
And, of course, everyone would get the second dose as soon as production catches up.
- pavelrub 6y agoThe main unknowns aren't around short-term efficacy, but long term immunity. If it turns out that a single dose provides ~80% protection but only for 3 months, whereas the second dose provides strong long-term protection, the one-dose scenario would be significantly worse.
- BurningFrog 6y agoLonger term, everyone gets a booster shot as soon as they're available.
- Bootvis 6y agoWhat if it takes 9 months to have the booster shots available? People will be vulnerable for 6 then.
- Exmoor 6y agoVulnerability isn't binary. You're not immune one day and susceptible the next. It's much more likely that immunity to getting sick might start decreasing over time, but still remain relatively high. So, perhaps 80% in 3 months, 60% in 6 months, and 30% in 9 months to use made up numbers. Additionally, production is still ramping up so it's highly unlikely that we'll have less vaccine in 3 months than currently. We'll also likely have 1-3 more approved vaccines by then as well.
- Bootvis 6y agoUnfortunately, we don't know the exact numbers so following this strategy (which I agree might make sense) is somewhat of a gamble. Maybe the numbers are not very favourable therefore the choice shouldn't be portrayed as such a simple one as in the comment I replied to.
- BurningFrog 6y agoAll choices here are gambles.